NCT04861051View on ClinicalTrials.gov

Understanding Ketamine's Dissociative Effects (KD Study)

PHASE1RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2028

Conditions

Epilepsy

Interventions

DRUG

Ketamine

Study participants will receive 0.5mg/kg of ketamine - one single infusion

Trial Locations (1)

94305

RECRUITING

Stanford University School of Medicine, Palo Alto

All Listed Sponsors

lead

Stanford University

OTHER